Consistent with this, histone deacetylase (HDAC) inhibitors reduce HIF-1α protein expression leading to down-regulation of VEGF and other angiogenesis-related genes [57], potentially explaining the reciprocal relationship between extent of muscle capillarity and the degree of COPD [58]. Here, HIF1A is linked to chronic obstructive pulmonary disease.